About Stevanato Group S.p.A.
https://www.stevanatogroup.comStevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines.

CEO
Franco Stevanato
Compensation Summary
(Year )
ETFs Holding This Stock
Summary
Showing Top 3 of 4
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership

CONESTOGA CAPITAL ADVISORS, LLC
Shares:8.09M
Value:$165.62M

NEUBERGER BERMAN GROUP LLC
Shares:4.87M
Value:$99.72M

T. ROWE PRICE INVESTMENT MANAGEMENT, INC.
Shares:3.55M
Value:$72.73M
Summary
Showing Top 3 of 156
About Stevanato Group S.p.A.
https://www.stevanatogroup.comStevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $303.17M ▲ | $35.78M ▼ | $36.06M ▲ | 11.9% ▲ | $0.13 ▲ | $72.68M ▲ |
| Q2-2025 | $280.04M ▲ | $37.22M ▲ | $29.7M ▲ | 10.61% ▲ | $0.11 ▲ | $62.38M ▲ |
| Q1-2025 | $256.6M ▼ | $35.26M ▲ | $26.52M ▼ | 10.33% ▼ | $0.1 ▼ | $57.16M ▼ |
| Q4-2024 | $330.6M ▲ | $31.3M ▼ | $48.31M ▲ | 14.61% ▲ | $0.18 ▲ | $87.31M ▼ |
| Q3-2024 | $277.87M | $33.42M | $30.03M | 10.81% | $0.11 | $103.32M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $113.33M ▲ | $2.41B ▲ | $976.9M ▲ | $1.44B ▲ |
| Q2-2025 | $94.17M ▲ | $2.35B ▲ | $953.42M ▲ | $1.4B ▼ |
| Q1-2025 | $90.72M ▼ | $2.32B ▼ | $908.28M ▼ | $1.42B ▲ |
| Q4-2024 | $98.27M ▲ | $2.33B ▲ | $924.43M ▲ | $1.4B ▲ |
| Q3-2024 | $78M | $2.21B | $891.55M | $1.32B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $49.13M ▲ | $47.22M ▲ | $-48.19M ▲ | $19.42M ▼ | $19.16M ▲ | $-1.17M ▲ |
| Q2-2025 | $39.11M ▲ | $44.91M ▼ | $-59.66M ▲ | $21.21M ▲ | $3.45M ▲ | $-15.36M ▼ |
| Q1-2025 | $35.11M ▲ | $99.84M ▲ | $-70.71M ▲ | $-35.75M ▼ | $-7.55M ▼ | $28.05M ▲ |
| Q4-2024 | $9.8M ▼ | $43.63M ▼ | $-91.03M ▲ | $-21.17M ▼ | $20.27M ▲ | $-45.25M ▲ |
| Q3-2024 | $95.64M | $112.14M | $-219.18M | $116.9M | $8.39M | $-110.24M |

CEO
Franco Stevanato
Compensation Summary
(Year )
ETFs Holding This Stock
Summary
Showing Top 3 of 4
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership

CONESTOGA CAPITAL ADVISORS, LLC
Shares:8.09M
Value:$165.62M

NEUBERGER BERMAN GROUP LLC
Shares:4.87M
Value:$99.72M

T. ROWE PRICE INVESTMENT MANAGEMENT, INC.
Shares:3.55M
Value:$72.73M
Summary
Showing Top 3 of 156






